Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
8,952,454
-
Shares change
-
-224,175
-
Total reported value, excl. options
-
$81,996,119
-
Value change
-
-$7,321,125
-
Number of buys
-
18
-
Number of sells
-
-19
-
Price
-
$9.16
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2021
54 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2021.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,952,454 shares
of 92,448,158 outstanding shares and own 9.68% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3,610,412 shares), MORGAN STANLEY (910,986 shares), BlackRock Inc. (794,466 shares), KORNITZER CAPITAL MANAGEMENT INC /KS (708,976 shares), VANGUARD GROUP INC (692,195 shares), FMR LLC (645,496 shares), Fosun International Ltd (282,408 shares), STATE STREET CORP (226,416 shares), GEODE CAPITAL MANAGEMENT, LLC (217,828 shares), and NORTHERN TRUST CORP (139,837 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.